RTP801 (also known as REDD1), a stress-related protein, is induced by several
environmental stresses such as ischemia and cigarette smoke. Although ischemia can …

Ginkgolide B (GKB) is a well-established neuroprotectant for acute ischemia stroke.
However, its cerebral exposure and real-time response remain elusive in acute …

Ginkgolide B (GB) has potent neuroprotective effects against ischemia-induced brain injury
in vivo and in vitro. However, the underlying mechanisms of GB's neuroprotection remain …

Glutamate is considered to be responsible for the pathogenesis of cerebral ischemia
disease.[Ca2+] i influx and reactive oxygen species (ROS) production are considered to be …

Abstract Background Ginkgetin, extracted from Ginkgo biloba L leaves, has been
demonstrated to have potential anti‐inflammatory and immune‐suppressive properties. But …

Introduction: Ginkgolide B (GB), which is an active constituent derived from Ginkgo biloba
leaves, has been reported to ameliorate Alzheimer's disease (AD), ischemic stroke, as well …

Diterpene ginkgolides meglumine injection (DGMI) is a therapeutic extract of Ginkgo biloba
L, which has been used for the treatment of cerebral ischemic stroke in China. Ginkgolides …

Ginkgo biloba, a natural biflavonoid isolated from Ginkgo biloba leaves, is reported to have
strong anti-inflammatory and immunosuppressive properties. The aim of this study is to …

Ginkgolide B (GB) has been demonstrated to have a variety of pharmacological actions.
Accumulating evidence indicates that GB may exert a protective effect on brain injury. The …

The present study was undertaken to identify whether prostaglandin E2 receptor is the
potential receptor/binding site for Ginkgolide A, Ginkgolide B, Ginkgolide K, and Bilobalide …